These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 22342356)

  • 1. Current rabies vaccines and prophylaxis schedules: preventing rabies before and after exposure.
    Warrell MJ
    Travel Med Infect Dis; 2012 Jan; 10(1):1-15. PubMed ID: 22342356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
    Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
    Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-dermal administration of rabies vaccines in developing countries: at an affordable cost.
    Verma R; Khanna P; Prinja S; Rajput M
    Hum Vaccin; 2011 Jul; 7(7):792-4. PubMed ID: 21734465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabies post-exposure vaccination in 2 visits within a week: A 4-site intradermal regimen.
    Warrell MJ
    Vaccine; 2019 Feb; 37(9):1131-1136. PubMed ID: 30691982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradermal rabies vaccination: the evolution and future of pre- and post-exposure prophylaxis.
    Warrell MJ
    Curr Top Microbiol Immunol; 2012; 351():139-57. PubMed ID: 21267707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rabies pre-exposure vaccination of children with purified chick embryo cell vaccine (PCECV).
    Malerczyk C; Vakil HB; Bender W
    Hum Vaccin Immunother; 2013 Jul; 9(7):1454-9. PubMed ID: 23571224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study.
    WHO Rabies Modelling Consortium
    Lancet Infect Dis; 2019 Jan; 19(1):102-111. PubMed ID: 30472178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intradermal pre-exposure rabies immunisation in New Zealand.
    Shaw MM; Leggat PA; Williams ML
    Travel Med Infect Dis; 2006 Jan; 4(1):29-33. PubMed ID: 16887722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2): an observational cohort study.
    Cantaert T; Borand L; Kergoat L; Leng C; Ung S; In S; Peng Y; Phoeun C; Hing C; Taing CN; Saman M; Ong S; Mey C; Choeung R; Ly S; Dussart P; Bourhy H; Tarantola A
    Lancet Infect Dis; 2019 Dec; 19(12):1355-1362. PubMed ID: 31570311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developments in human rabies prophylaxis.
    Warrell MJ
    Rev Sci Tech; 2018 Aug; 37(2):629-647. PubMed ID: 30747121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postexposure rabies prophylaxis completed in 1 week: preliminary study.
    Shantavasinkul P; Tantawichien T; Wilde H; Sawangvaree A; Kumchat A; Ruksaket N; Lohsoonthorn V; Khawplod P; Tantawichien T
    Clin Infect Dis; 2010 Jan; 50(1):56-60. PubMed ID: 19995217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
    Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should travellers in rabies endemic areas receive pre-exposure rabies immunization?
    Phanuphak P; Ubolyam S; Sirivichayakul S
    Ann Med Interne (Paris); 1994; 145(6):409-11. PubMed ID: 7864502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One or three intradermal injections within one week for rabies pre-exposure immunization.
    Khawplod P; Wilde H; Sriaroon C; Chomchey P; Kamolthum T; Sitprija V
    Dev Biol (Basel); 2008; 131():393-401. PubMed ID: 18634501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults.
    Kerdpanich P; Chanthavanich P; De Los Reyes MR; Lim J; Yu D; Ama MC; Mojares Z; Casula D; Arora AK; Pellegrini M
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006340. PubMed ID: 29874228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trend of human rabies prophylaxis in developing countries: toward optimal rabies immunization.
    Permpalung N; Wongrakpanich S; Korpaisarn S; Tanratana P; Angsanakul J
    Vaccine; 2013 Aug; 31(38):4079-83. PubMed ID: 23845809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An effective economical intradermal regimen of human diploid cell rabies vaccination for post-exposure treatment.
    Ubol S; Phanuphak P
    Clin Exp Immunol; 1986 Mar; 63(3):491-7. PubMed ID: 3708902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabies antibody seroprotection rates among travelers in Nepal: "rabies seroprotection in travelers".
    Ranney M; Partridge R; Jay GD; Rozzoli DE; Pandey P
    J Travel Med; 2006; 13(6):329-33. PubMed ID: 17107424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simplification of Rabies Postexposure Prophylaxis: A New 2-Visit Intradermal Vaccine Regimen.
    Warrell MJ
    Am J Trop Med Hyg; 2019 Dec; 101(6):1199-1201. PubMed ID: 31392953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postexposure prophylaxis for rabies in resource-limited/poor countries.
    Shantavasinkul P; Wilde H
    Adv Virus Res; 2011; 79():291-307. PubMed ID: 21601051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.